PERIOGARD MOUTHWASH

Šalis: Kanada

kalba: anglų

Šaltinis: Health Canada

Veiklioji medžiaga:

CHLORHEXIDINE GLUCONATE

Prieinama:

COLGATE-PALMOLIVE CANADA INC

ATC kodas:

A01AB03

INN (Tarptautinis Pavadinimas):

CHLORHEXIDINE

Dozė:

0.12%

Vaisto forma:

MOUTHWASH

Sudėtis:

CHLORHEXIDINE GLUCONATE 0.12%

Vartojimo būdas:

BUCCAL

Vienetai pakuotėje:

473ML

Recepto tipas:

Prescription

Gydymo sritis:

MISCELLANEOUS ANTI-INFECTIVES

Produkto santrauka:

Active ingredient group (AIG) number: 0107629007; AHFS:

Autorizacija statusas:

CANCELLED POST MARKET

Leidimo data:

2022-03-30

Prekės savybės

_Page 1 of 19_
PRODUCT MONOGRAPH
CHLORHEXIDINE GLUCONATE ORAL RINSE
Chlorhexidine Gluconate 0.12% Oral Rinse Liquid, USP
0.12% Chlorhexidine Gluconate Antigingivital Oral Rinse
Colgate-Palmolive Canada Inc.
Two Morneau Shepell Centre, 5
th
Floor,
895 Don Mills Road,
Toronto, Ontario
M3C 1W3
Submission Control No.: 207101
Date of Preparation:
August 17, 2017
_Page 2 of 19_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION.....................................................3
SUMMARY PRODUCT INFORMATION
................................................................3
INDICATIONS AND CLINICAL USE
......................................................................3
CONTRAINDICATIONS
.........................................................................................3
WARNINGS AND PRECAUTIONS
........................................................................4
ADVERSE
REACTIONS.........................................................................................6
DOSAGE AND ADMINISTRATION
........................................................................6
OVERDOSAGE
.....................................................................................................7
ACTION AND CLINICAL PHARMACOLOGY
........................................................8
STORAGE AND STABILITY
..................................................................................9
SPECIAL HANDLING INSTRUCTIONS
................................................................9
DOSAGE FORMS, COMPOSITION AND PACKAGING
.....................................10
PART II: SCIENTIFIC INFORMATION
..........................................................................11
PHARMACEUTICAL
INFORMATION..................................................................11
CLINICAL TRIALS
................................................................................................12
DETAILED PHARMACOLOGY
............................................................................13
MICROBIOLOGY
..............................